SUMMARY The intracellular sodium, potassium, and water content of isolated leucocytes was estimated in 47 patients with cirrhosis. The values for sodium showed a wide scatter. In patients without ascites the mean value was significantly increased but in those accumulating ascites it was normal, although often reduced in individual subjects. Reduced values were found in patients with hyponatraemia associated with end-stage cirrhosis and diuretic treatment. Changes in leucocyte water content closely followed those in sodium content. Leucocyte potassium content was normal except in patients accumulating ascites in whom it was significantly reduced, indicating whole body depletion, and this could be corrected by administration of spironolactone.
Abnormalities of plasma electrolyte concentrations, particularly hyponatraemia and hypokalaemia, are common in cirrhosis especially when ascites is present. Total body measurements have also been reported to be abnormal, with increases in total exchangeable sodium and water (Birkenfeld et al., 1958; Nagant de Deuxchaisnes et al., 1961; Traverso et al., 1966) and reductions in total exchangeable potassium (42K) (Birkenfeld et al., 1958; Casey et al., 1965) , and total body potassium (40K) (Soler et al., 1976) . Since a large proportion of the electrolyte content of the body is intracellular, changes can be satisfactorily analysed only when both serum values and intracellular electrolyte content are determined. Afifi et al. (1968) reported an increased erythrocyte sodium content in patients with cirrhosis and ascites, but Strub et al. (1955) found no significant abnormalities in intracellular electrolytes as determined on muscle fibre specimens. No consistent changes in leucocyte sodium, potassium, or water were found by Roberts and Baron (1963) in an unspecified number of patients with 'chronic hepatic failure' all of whom had received diuretics. The same group has more recently reported a significant increase in cell water in 13 patients with ascites (Levin and Baron, 1975 Leucocytes were separated from peripheral blood by the method of Baron and Ahmed (1969) . This involved dextran sedimentation of erythrocytes from approximately 15 ml of peripheral blood and removal of residual erythrocytes by hypotonic lysis. Leucocytes were then resuspended in a tissue culture medium (Tc 199) and 1251 human serum albumin added as an extracellular fluid marker. Viability of the leucocytes was demonstrated at this stage by trypan blue exclusion and phase contrast microscopy in the first 12 patients, and at regular intervals thereafter. Cells were then dried, and treated with 0-1 N HNO3 before the final reading for electrolytes was taken (Baron and Ahmed, 1969 (1974) . Statistical comparisons between patient groups and normal subjects were made using Student's t test.
Results
Of the 11 patients without ascites (group A), seven had raised values for leucocyte sodium content and only two were low. The mean value was 108 mmol/kg (± SD 49) which is significantly higher than 80 mmol/kg (± SD 5) found in the 24 normal subjects (Table, Fig. 1) .
A wide scatter of values was also found in group B, those accumulating ascites, but the mean was not significantly different from that of the normal subjects.
In those patients with diuretic-induced hyponatraemia (group C) and in those with hyponatraemia associated with end-stage cirrhosis (group D), the leucocyte sodium content, with three exceptions, was below the normal range. The mean values for both groups were significantly reduced, being 23 mmol/kg (± SD 17), and 47 mmol/kg (± SD 28) respectively (Table) .
Values for leucocyte water closely followed those for leucocyte sodium, being reduced in most of the patients in groups C and D, and not significantly different from normal in groups A and B (Table, Fig. 1 ). The correlation coefficient between the values for intracellular water and intracellular sodium, for the complete series of patients, was r = + 0-587 (p < 0'001).
The mean leucocyte potassium content was within Fig. 1 ).
In the nine patients of group B studied before and after induction of a diuresis with spironolactone a significant reduction in the leucocyte sodium content was observed (p < 0 05, paired t test) (Fig. 2) . The plasma sodium concentration did not change significantly with mean values of 130 mmol/l ± SD 6 before and 132 mmol/l ± SD 4 after treatment. Overall there was no significant change in leucocyte potassium content (p > 0 05, paired t test), but, if the five patients in whom this was reduced before treatment are considered separately, there was a significant rise after spironolactone (p < 0(005) (Fig. 2) . The plasma potassium concentration showed a significant rise after treatment, from 3-7 mmol/l + SD 0-4 to 4-5 mmol/l ± SD 0-6 (p < 0 005).
Discussion
The wide variation in leucocyte sodium content was striking. This was particularly surprising in the patients with cirrhosis uncomplicated by ascites (group A), representing a stage of the disease at which there is no clinical evidence for abnormal sodium metabolism and when the plasma sodium concentration is normal. The present studies throw no light on the mechanisms involved in these changes, but one possibility is that the raised leucocyte sodium content in many of the patients in group A and in a number of those accumulating ascites (group B), is related to whole body magnesium status. Magnesium depletion has been described in cirrhosis both with and without ascites (Lim and Jacob, 1972) and it can also result in a reduced activity of the cell membrane sodium pump (Renn et al., 1967) . Furthermore, magnesium deficiency has been shown to be associated with a raised erythrocyte sodium content (Whang and Welt, 1963) . However, in many of the patients in group B, and in most of those with end-stage cirrhosis (group D), in all of whom sodium retention was the rule, the measured leucocyte sodium content was decreased. This suggests stimulation of the sodium pump which could in turn be due to the action of aldosterone, the plasma concentrations of which are characteristically raised in such patients (Wolff et al., 1966) , particularly since it has been demonstrated that aldosterone increases the rate of sodium efflux from various tissues including kidney tubules (Traverso et al., 1966) , they also have a markedly reduced renal capacity to excrete free water (Shear et al., 1965), .and so by inference dilution of the extracellular space is the likely cause of the hyponatraemia. The present findings are in marked contrast to those in patients with fulminant hepatic failure resulting from viral hepatitis, paracetamol overdose, or halothaneassociated hepatitis, in whom we have found hyponatraemia to be associated with high values for the leucocyte sodium content .
The lowest levels of leucocyte sodium were found in patients with a diuretic-induced hyponatraemia *(group C) and as they had been in negative sodium balance, true sodium depletion would seem to have contributed Iowards this. However, as a result of *extracellular fluid volume depletion, the kidneys retain water because of both increased secretion of .antidiuretic hormone (Kleeman and Fichman, 1967; Fichman et al., 1971) and also because there is an increased proximal tubular reabsorption of sodium (Earley and Orloff, 1962; Fichman et at., 1971) , the latter limiting the amount of sodium available to the ascending limb of the loop of Henle for generation of free water. These factors are likely to contribute to an added dilutional effect in the development of the hyponatraemia. Furthermore, diuretics are potent stimuli to aldosterone secretion, this possibly resulting in an increased sodium efflux from cells.
The possibility raised by some authors (Fichman et al., 1971 ) that diuretic-induced hyponatraemia may be partly the result of sodium passing into cells in response to associated potassium depletion seems unlikely on the basis of our results.
Values for leucocyte water content followed those for leucocyte sodium and this was taken to represent a tendency towards maintenance of osmotic equilibrium.
The (Traverso et al., 1966) . These findings are of clinical relevance. The reduced leucocyte potassium in the patients accumulating ascites substantiates the view of others that potassium depletion is characteristic of this stage of the disease (Casey et al., 1965; Traverso et al., 1966) . The use of 'potassium-losing' diuretics such as frusemide and thiazides should therefore be avoided if possible since further potassium depletion may lead to hepatic encephalopathy both by increasing renal ammonia production (Gabuzda and Hall, 1966) and as a result of the induced metabolic alkalosis facilitating uptake of ammonia by brain cells (Warren et al., 1960) . The use of spironolactone, a 'potassium-sparing' diuretic, is preferable since it not only directly antagonises the action of aldosterone, but in the present study abnormally low values for leucocyte potassium were corrected following its use. We have recently shown that patients receiving spironolactone alone as maintenance treatment for ascites have a normal whole body potassium (Wheeler et al., 1977) . A further reason for avoiding the use of frusemide is that the development of hyponatraemia was invariably associated with its use (group C). Since a spontaneously occurring hyponatraemia in association with end-stage cirrhosis appears to be due to a relative water overload, rigid water restriction is the most logical form of treatment.
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